MedTrace Logo

Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula

NCT04934397 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2022-06-09

No results posted yet for this study

Summary

To assess the effects of partially hydrolyzed whey protein-based infant formula with oligosaccharides on symptoms of formula intolerance in healthy, term infants.

Conditions

  • Gastro-Intestinal Tolerance

Interventions

OTHER

Study Infant Formula

Powdered partially hydrolyzed whey (WPH) based infant formula with oligosaccharides

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • John Lasekan, PhD, MS, MBA, CCRP · Abbott Nutrition

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
7 Days
Max Age
65 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-08
Primary Completion
2022-02-18
Completion
2022-02-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04934397 on ClinicalTrials.gov